Jackson Wealth Management LLC bought a new position in CME Group Inc. (NASDAQ:CME) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 16,044 shares of the financial services provider’s stock, valued at approximately $1,986,000.

A number of other hedge funds also recently modified their holdings of the stock. Alliancebernstein L.P. boosted its holdings in CME Group by 4.7% in the second quarter. Alliancebernstein L.P. now owns 624,825 shares of the financial services provider’s stock worth $78,253,000 after purchasing an additional 28,051 shares during the last quarter. Pittenger & Anderson Inc. boosted its holdings in CME Group by 27.8% in the second quarter. Pittenger & Anderson Inc. now owns 56,755 shares of the financial services provider’s stock worth $7,108,000 after purchasing an additional 12,360 shares during the last quarter. Aberdeen Asset Management PLC UK boosted its holdings in CME Group by 24.0% in the second quarter. Aberdeen Asset Management PLC UK now owns 831,899 shares of the financial services provider’s stock worth $104,187,000 after purchasing an additional 160,830 shares during the last quarter. Sand Hill Global Advisors LLC boosted its holdings in CME Group by 2.8% in the second quarter. Sand Hill Global Advisors LLC now owns 43,174 shares of the financial services provider’s stock worth $5,407,000 after purchasing an additional 1,178 shares during the last quarter. Finally, AXA boosted its holdings in CME Group by 17.3% in the second quarter. AXA now owns 242,300 shares of the financial services provider’s stock worth $30,346,000 after purchasing an additional 35,800 shares during the last quarter. Institutional investors own 82.66% of the company’s stock.

Shares of CME Group Inc. (NASDAQ CME) traded up 1.83% on Friday, hitting $128.04. 1,034,854 shares of the stock traded hands. The stock has a 50 day moving average of $124.85 and a 200 day moving average of $121.77. CME Group Inc. has a one year low of $98.95 and a one year high of $129.31. The company has a market cap of $43.52 billion, a PE ratio of 26.14 and a beta of 0.72.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Tuesday, August 1st. The financial services provider reported $1.23 EPS for the quarter, beating the consensus estimate of $1.20 by $0.03. The business had revenue of $925 million for the quarter, compared to the consensus estimate of $931.05 million. CME Group had a net margin of 46.05% and a return on equity of 7.61%. The business’s revenue for the quarter was up 2.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.14 EPS. Equities analysts anticipate that CME Group Inc. will post $4.81 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Friday, September 8th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Thursday, September 7th. CME Group’s dividend payout ratio (DPR) is presently 53.99%.

CME has been the topic of several research reports. Deutsche Bank AG restated a “buy” rating and issued a $133.00 target price (down previously from $134.00) on shares of CME Group in a report on Monday, May 15th. Jefferies Group LLC reiterated a “buy” rating and set a $134.00 price target (up previously from $128.00) on shares of CME Group in a research note on Monday, July 17th. Royal Bank Of Canada set a $130.00 price target on shares of CME Group and gave the stock a “buy” rating in a research note on Monday, June 12th. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. Finally, UBS AG reiterated a “buy” rating and set a $135.00 price target (up previously from $134.00) on shares of CME Group in a research note on Wednesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have assigned a buy rating to the stock. CME Group has a consensus rating of “Buy” and a consensus price target of $132.56.

TRADEMARK VIOLATION WARNING: This piece was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/09/16044-shares-in-cme-group-inc-cme-acquired-by-jackson-wealth-management-llc.html.

In related news, President Bryan T. Durkin sold 9,200 shares of the stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $125.13, for a total transaction of $1,151,196.00. Following the sale, the president now directly owns 70,938 shares of the company’s stock, valued at $8,876,471.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Hilda Harris Piell sold 714 shares of the stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $129.00, for a total transaction of $92,106.00. Following the sale, the insider now directly owns 28,844 shares in the company, valued at $3,720,876. The disclosure for this sale can be found here. Insiders have sold 68,134 shares of company stock worth $8,531,537 over the last three months. 0.57% of the stock is currently owned by insiders.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.